Hospitalizations can be disruptive and costly for Medicare-Medicaid enrollees residing in nursing facilities. Research shows that nearly 45 percent of hospitalizations among this population are avoidable, meaning they could have been prevented or treated in a lower intensity care setting. For more information on this initiative, please go to .
Improving the care experience for individuals who are Medicare-Medicaid enrollees – sometimes referred to as “dual eligibles” – is a critical priority for CMS. Currently, Medicare-Medicaid enrollees navigate multiple sets of rules, benefits, and providers Parts A, B, and D and Medicaid). Total annual spending for their care is approximately $300 billion across both programs. Medicare-Medicaid enrollees are among the most chronically ill and complex enrollees in both programs.
Interestingly, in our analysis, some of the factors included in previously devised prognostic models did not retain prognostic value. This is particularly true for the number of metastatic sites that is included in the RMH score, which is one of the most widely accepted and externally validated prognostic algorithms. This discrepancy may have accounted for the relative underperformance of the RMH in our series. In addition, the original case series used to devise and validate the RMH score was only compos
Placebo mechanisms contribute substantially to clinical treatments in various fields of medicine, but systematic approaches to utilize these mechanisms for improved outcome are scarce [, ]. While placebo effects are substantial for patient-reported outcomes such as pain or depression, placebo effects can be also demonstrated for objective parameters such as immune responses, cardiovascular parameters, dopamine release, electroencephalogram and functional magnetic resonance imaging parameters . Major deter